105 related articles for article (PubMed ID: 27665942)
1. CYR61 suppresses growth of human malignant melanoma.
Chen J; Liu Y; Sun Q; Wang B; Li N; Chen X
Oncol Rep; 2016 Nov; 36(5):2697-2704. PubMed ID: 27665942
[TBL] [Abstract][Full Text] [Related]
2. Silencing cAMP-response element-binding protein (CREB) identifies CYR61 as a tumor suppressor gene in melanoma.
Dobroff AS; Wang H; Melnikova VO; Villares GJ; Zigler M; Huang L; Bar-Eli M
J Biol Chem; 2009 Sep; 284(38):26194-206. PubMed ID: 19632997
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA CPS1-IT1 suppresses melanoma cell metastasis through inhibiting Cyr61 via competitively binding to BRG1.
Zhou X; Rao Y; Sun Q; Liu Y; Chen J; Bu W
J Cell Physiol; 2019 Dec; 234(12):22017-22027. PubMed ID: 31111478
[TBL] [Abstract][Full Text] [Related]
4. A novel anti-Cyr61 antibody inhibits breast cancer growth and metastasis in vivo.
Lin J; Huo R; Wang L; Zhou Z; Sun Y; Shen B; Wang R; Li N
Cancer Immunol Immunother; 2012 May; 61(5):677-87. PubMed ID: 22048717
[TBL] [Abstract][Full Text] [Related]
5. Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells.
Koch A; Lang SA; Wild PJ; Gantner S; Mahli A; Spanier G; Berneburg M; Müller M; Bosserhoff AK; Hellerbrand C
Oncotarget; 2015 Oct; 6(32):32748-60. PubMed ID: 26293674
[TBL] [Abstract][Full Text] [Related]
6. Resveratrol analogue, trans-4,4'-dihydroxystilbene (DHS), inhibits melanoma tumor growth and suppresses its metastatic colonization in lungs.
Saha B; Pai GB; Subramanian M; Gupta P; Tyagi M; Patro BS; Chattopadhyay S
Biomed Pharmacother; 2018 Nov; 107():1104-1114. PubMed ID: 30257322
[TBL] [Abstract][Full Text] [Related]
7. Cyr61/CCN1 is a tumor suppressor in human hepatocellular carcinoma and involved in DNA damage response.
Feng P; Wang B; Ren EC
Int J Biochem Cell Biol; 2008; 40(1):98-109. PubMed ID: 17698398
[TBL] [Abstract][Full Text] [Related]
8. Matricellular TSP-1 as a target of interest for impeding melanoma spreading: towards a therapeutic use for TAX2 peptide.
Jeanne A; Boulagnon-Rombi C; Devy J; Théret L; Fichel C; Bouland N; Diebold MD; Martiny L; Schneider C; Dedieu S
Clin Exp Metastasis; 2016 Oct; 33(7):637-49. PubMed ID: 27349907
[TBL] [Abstract][Full Text] [Related]
9. Cyr61 is a target for heparin in reducing MV3 melanoma cell adhesion and migration via the integrin VLA-4.
Schmitz P; Gerber U; Schütze N; Jüngel E; Blaheta R; Naggi A; Torri G; Bendas G
Thromb Haemost; 2013 Nov; 110(5):1046-54. PubMed ID: 24009013
[TBL] [Abstract][Full Text] [Related]
10. Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors.
Habel N; Vilalta M; Bawa O; Opolon P; Blanco J; Fromigué O
Oncogene; 2015 Jun; 34(24):3207-13. PubMed ID: 25065593
[TBL] [Abstract][Full Text] [Related]
11. Cyr61 promotes growth of glioblastoma in vitro and in vivo.
Cheng G; Zhang H; Zhang L; Zhang J
Tumour Biol; 2015 Apr; 36(4):2869-73. PubMed ID: 25501701
[TBL] [Abstract][Full Text] [Related]
12. CYR61 downregulation reduces osteosarcoma cell invasion, migration, and metastasis.
Fromigue O; Hamidouche Z; Vaudin P; Lecanda F; Patino A; Barbry P; Mari B; Marie PJ
J Bone Miner Res; 2011 Jul; 26(7):1533-42. PubMed ID: 21312266
[TBL] [Abstract][Full Text] [Related]
13. CYR61 triggers osteosarcoma metastatic spreading via an IGF1Rβ-dependent EMT-like process.
Habel N; Stefanovska B; Carène D; Patiño-Garcia A; Lecanda F; Fromigué O
BMC Cancer; 2019 Jan; 19(1):62. PubMed ID: 30642298
[TBL] [Abstract][Full Text] [Related]
14. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
Wang G; Gu J; Gao Y
Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.
Passeron T; Valencia JC; Namiki T; Vieira WD; Passeron H; Miyamura Y; Hearing VJ
J Clin Invest; 2009 Apr; 119(4):954-63. PubMed ID: 19273910
[TBL] [Abstract][Full Text] [Related]
17. The nitrobenzoxadiazole derivative MC3181 blocks melanoma invasion and metastasis.
De Luca A; Carpanese D; Rapanotti MC; Viguria TM; Forgione MA; Rotili D; Fulci C; Iorio E; Quintieri L; Chimenti S; Bianchi L; Rosato A; Caccuri AM
Oncotarget; 2017 Feb; 8(9):15520-15538. PubMed ID: 28107182
[TBL] [Abstract][Full Text] [Related]
18. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
Goodwin CR; Lal B; Zhou X; Ho S; Xia S; Taeger A; Murray J; Laterra J
Cancer Res; 2010 Apr; 70(7):2932-41. PubMed ID: 20233866
[TBL] [Abstract][Full Text] [Related]
19. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
[TBL] [Abstract][Full Text] [Related]
20. Targeting the cyclin-dependent kinase 5 in metastatic melanoma.
Sharma S; Zhang T; Michowski W; Rebecca VW; Xiao M; Ferretti R; Suski JM; Bronson RT; Paulo JA; Frederick D; Fassl A; Boland GM; Geng Y; Lees JA; Medema RH; Herlyn M; Gygi SP; Sicinski P
Proc Natl Acad Sci U S A; 2020 Apr; 117(14):8001-8012. PubMed ID: 32193336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
